Tagnères, Sophie http://orcid.org/0009-0008-7830-2136
Santo, Paulo Espirito
Radermecker, Julie
Rinaldi, Dana
Froment, Carine
Provost, Quentin
Bongers, Manon
Capeille, Solemne
Watkins, Nick
Marcoux, Julien http://orcid.org/0000-0001-7321-7436
Gleizes, Pierre-Emmanuel http://orcid.org/0000-0003-0830-7341
Marcel, Virginie http://orcid.org/0000-0002-9557-8221
Plisson-Chastang, Célia http://orcid.org/0000-0002-8439-8428
Lebaron, Simon http://orcid.org/0000-0001-7348-2088
Funding for this research was provided by:
Ligue Contre le Cancer (62339, Labelisation)
Institut National Du Cancer (PLBIO022-065)
Article History
Received: 21 November 2023
Accepted: 16 September 2024
First Online: 27 September 2024
Competing interests
: S.T., S.L., V.M., C.P.C., and P.E.G. have filed a patent application on the targeting of SURF2 in cancer, therapies and ribosomopathies treatments. The remaining authors declare no competing interests.